IGC Pharma’s (IGC) “Buy” Rating Reiterated at Alliance Global Partners
Alliance Global Partners reissued their buy rating on shares of IGC Pharma (NYSEMKT:IGC – Free Report) in a report published on Thursday morning,Benzinga reports. Alliance Global Partners currently has a $3.50 price objective on the stock. Separately, Ascendiant Capital Markets raised their target price on IGC Pharma from $4.00 to $4.25 and gave the company […]
Alliance Global Partners reissued their buy rating on shares of IGC Pharma (NYSEMKT:IGC – Free Report) in a report published on Thursday morning,Benzinga reports. Alliance Global Partners currently has a $3.50 price objective on the stock. Separately, Ascendiant Capital Markets raised their target price on IGC Pharma from $4.00 to $4.25 and gave the company […]
